Uche IK, Fowlkes N, Vu L, Watanabe T, et al. The Novel Oncolytic Herpes Simplex Virus Type-1 (HSV-1) VC2 Promotes Long-lasting, Systemic Anti-melanoma Tumor Immune Responses and Increased Survival in an Immunocompetent B16F10-derived Mouse Melanoma Model. J Virol 2020 Nov 11. pii: JVI.01359-20. doi: 10.1128/JVI.01359.
PMID: 33177208